«Effectiveness and safety of the monoclonal antibody drug lecanemab (Leqembi) in reducing beta-amyloid plaques in alzheimer’s dementia: a literature review» (2025) Journal of Health Management and Pharmacy Exploration, 3(1). doi:10.52465/johmpe.v3i1.547.